Gene · 4591
NIH grants974
NIH grants whose papers are about the gene, through NIH's grant-paper links.
241 to 260 of 974
Download this page as JSON| Grant | Title | TRIM37 papers | Newest fiscal year |
|---|---|---|---|
| R01AI149672 | Defining Mechanisms of Viral Persistence in Situ at the Single-Cell Level | 2 | 2024 |
| T32GM007863 | Michigan Medical Scientist Training Program | 2 | 2024 |
| U01DA036935 | Johns Hopkins HIV Clinical Cohort | 2 | 2024 |
| U24AI120134 | Development of multi-modal single-cell technology to dissect epitope specificity to HIV | 2 | 2024 |
| F31CA257090 | Expanding the Druggable Human Genome | 1 | 2024 |
| KL2TR001999 | Institutional Career Development Core | 1 | 2024 |
| P01AI138962 | Inherited T cell defects: Diagnosis, Mechanisms and Treatments | 1 | 2024 |
| P01CA174653 | DNA double-strand break repair, chromosome translocations and cancer | 1 | 2024 |
| P42ES013648 | LSU Superfund Research Center - Environmentally Persistent Free Radicals | 1 | 2024 |
| P50CA098131 | SPORE in Breast Cancer | 1 | 2024 |
| R01AI087390 | Modulation of retroviral uncoating by cellular factors | 1 | 2024 |
| R01AI139074 | Elucidating strategies of Staphylococcus aureus nutrient sulfur acquisition during infection | 1 | 2024 |
| R01AR065538 | Ly6 family members in neutrophil biology | 1 | 2024 |
| R01CA138804 | Role of PALB2 in the DNA Damage Response and Cancer Suppression | 1 | 2024 |
| R01CA168762 | Onset and biomarkers for progression of monoclonal gammopathies | 1 | 2024 |
| R01CA237500 | Standardized Molecular Analyses of Glioma EVs | 1 | 2024 |
| R01CA239078 | Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring | 1 | 2024 |
| R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 1 | 2024 |
| R01CA244254 | Development of ASH1L inhibitors for acute leukemia | 1 | 2024 |
| R01CA244899 | Development of a multi-omic clinical decision platform to guide personalized therapy | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4591/grants?page=13